1. Home
  2. DH vs QTTB Comparison

DH vs QTTB Comparison

Compare DH & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DH
  • QTTB
  • Stock Information
  • Founded
  • DH 2011
  • QTTB 2015
  • Country
  • DH United States
  • QTTB United States
  • Employees
  • DH N/A
  • QTTB N/A
  • Industry
  • DH Computer Software: Prepackaged Software
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • DH Technology
  • QTTB Health Care
  • Exchange
  • DH Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • DH 518.7M
  • QTTB 434.0M
  • IPO Year
  • DH 2021
  • QTTB N/A
  • Fundamental
  • Price
  • DH $4.18
  • QTTB $3.59
  • Analyst Decision
  • DH Hold
  • QTTB Buy
  • Analyst Count
  • DH 11
  • QTTB 8
  • Target Price
  • DH $6.15
  • QTTB $29.14
  • AVG Volume (30 Days)
  • DH 518.0K
  • QTTB 669.8K
  • Earning Date
  • DH 11-07-2024
  • QTTB 11-07-2024
  • Dividend Yield
  • DH N/A
  • QTTB N/A
  • EPS Growth
  • DH N/A
  • QTTB N/A
  • EPS
  • DH N/A
  • QTTB N/A
  • Revenue
  • DH $255,846,000.00
  • QTTB N/A
  • Revenue This Year
  • DH $2.58
  • QTTB N/A
  • Revenue Next Year
  • DH N/A
  • QTTB N/A
  • P/E Ratio
  • DH N/A
  • QTTB N/A
  • Revenue Growth
  • DH 3.97
  • QTTB N/A
  • 52 Week Low
  • DH $3.19
  • QTTB $3.02
  • 52 Week High
  • DH $10.62
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • DH 37.96
  • QTTB 16.82
  • Support Level
  • DH $4.05
  • QTTB $3.02
  • Resistance Level
  • DH $4.64
  • QTTB $28.06
  • Average True Range (ATR)
  • DH 0.20
  • QTTB 2.02
  • MACD
  • DH -0.06
  • QTTB -0.96
  • Stochastic Oscillator
  • DH 16.67
  • QTTB 2.28

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of its revenue from the United States.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: